Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nazar Trotsko

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
European Journal of Medicinal Chemistry|January 18, 2020
Synthesis and antimycobacterial activity of thiazolidine-2,4-dione based derivatives with halogenbenzohydrazones and pyridinecarbohydrazones substituentsNazar Trotsko, Joanna Golus, Paulina Kazimierczak, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|February 26, 2013
Cytotoxicity and topoisomerase I/II inhibition activity of novel 4-aryl/alkyl-1-(piperidin-4-yl)-carbonylthiosemicarbazides and 4-benzoylthiosemicarbazidesAgata Siwek, Anna Bielawska, Elzbieta Maciorkowska, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 27, 2022
Inhibition of <i>Toxoplasma gondii</i> by 1,2,4-triazole-based compounds: marked improvement in selectivity relative to the standard therapy pyrimethamine and sulfadiazineLidia Węglińska, Adrian Bekier, Nazar Trotsko, et al.
International Journal of Molecular Sciences|October 16, 2025
Dermatophyte-Selective Imidazole-Thiosemicarbazides: Potent In Vitro Activity Against <i>Trichophyton</i> and <i>Microsporum</i> with No Anti-<i>Candida</i> EffectAgata Paneth, Katarzyna Dzitko, Adrian Bekier, et al.
Bioorganic Chemistry|February 26, 2020
Design, synthesis and antimycobacterial activity of thiazolidine-2,4-dione-based thiosemicarbazone derivativesNazar Trotsko, Joanna Golus, Paulina Kazimierczak, et al.
International Journal of Molecular Sciences|February 11, 2023
TZD-Based Hybrid Molecules Act as Dual Anti-<i>Mycobacterium tuberculosis</i> and Anti-<i>Toxoplasma gondii</i> AgentsKatarzyna Dzitko, Barbara Kaproń, Agata Paneth, et al.
International Journal of Molecular Sciences|November 27, 2024
Rhodanine-Piperazine Hybrids as Potential VEGFR, EGFR, and HER2 Targeting Anti-Breast Cancer AgentsJacek Szczepański, Dmytro Khylyuk, Agnieszka Korga-Plewko, et al.
Chemistry & Biodiversity|August 23, 2019
Synthesis and Antibacterial Evaluation of Mannich Bases Derived from 1,2,4-TriazoleAgata Paneth, Nazar Trotsko, Łukasz Popiołek, et al.
Molecules (Basel, Switzerland)|April 27, 2019
Discovery of Potent and Selective Halogen-Substituted Imidazole-Thiosemicarbazides for Inhibition of <i>Toxoplasma gondii</i> Growth In Vitro via Structure-Based DesignAgata Paneth, Lidia Węglińska, Adrian Bekier, et al.
Frontiers in Immunology|February 23, 2026
Recombinant ROP8 antigen: diagnostics, immunogenicity, and therapeutic targeting in toxoplasmosisMaciej Chyb, Adrian Bekier, Malwina Kawka, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
European Journal of Medicinal Chemistry|January 18, 2020
Synthesis and antimycobacterial activity of thiazolidine-2,4-dione based derivatives with halogenbenzohydrazones and pyridinecarbohydrazones substituentsNazar Trotsko, Joanna Golus, Paulina Kazimierczak, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|February 26, 2013
Cytotoxicity and topoisomerase I/II inhibition activity of novel 4-aryl/alkyl-1-(piperidin-4-yl)-carbonylthiosemicarbazides and 4-benzoylthiosemicarbazidesAgata Siwek, Anna Bielawska, Elzbieta Maciorkowska, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 27, 2022
Inhibition of <i>Toxoplasma gondii</i> by 1,2,4-triazole-based compounds: marked improvement in selectivity relative to the standard therapy pyrimethamine and sulfadiazineLidia Węglińska, Adrian Bekier, Nazar Trotsko, et al.
International Journal of Molecular Sciences|October 16, 2025
Dermatophyte-Selective Imidazole-Thiosemicarbazides: Potent In Vitro Activity Against <i>Trichophyton</i> and <i>Microsporum</i> with No Anti-<i>Candida</i> EffectAgata Paneth, Katarzyna Dzitko, Adrian Bekier, et al.
Bioorganic Chemistry|February 26, 2020
Design, synthesis and antimycobacterial activity of thiazolidine-2,4-dione-based thiosemicarbazone derivativesNazar Trotsko, Joanna Golus, Paulina Kazimierczak, et al.
International Journal of Molecular Sciences|February 11, 2023
TZD-Based Hybrid Molecules Act as Dual Anti-<i>Mycobacterium tuberculosis</i> and Anti-<i>Toxoplasma gondii</i> AgentsKatarzyna Dzitko, Barbara Kaproń, Agata Paneth, et al.
International Journal of Molecular Sciences|November 27, 2024
Rhodanine-Piperazine Hybrids as Potential VEGFR, EGFR, and HER2 Targeting Anti-Breast Cancer AgentsJacek Szczepański, Dmytro Khylyuk, Agnieszka Korga-Plewko, et al.
Chemistry & Biodiversity|August 23, 2019
Synthesis and Antibacterial Evaluation of Mannich Bases Derived from 1,2,4-TriazoleAgata Paneth, Nazar Trotsko, Łukasz Popiołek, et al.
Molecules (Basel, Switzerland)|April 27, 2019
Discovery of Potent and Selective Halogen-Substituted Imidazole-Thiosemicarbazides for Inhibition of <i>Toxoplasma gondii</i> Growth In Vitro via Structure-Based DesignAgata Paneth, Lidia Węglińska, Adrian Bekier, et al.
Frontiers in Immunology|February 23, 2026
Recombinant ROP8 antigen: diagnostics, immunogenicity, and therapeutic targeting in toxoplasmosisMaciej Chyb, Adrian Bekier, Malwina Kawka, et al.
Pageof 4